Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 6:56 AM ET


Company Overview of Sonus Pharmaceuticals Inc.

Company Overview

As of August 20, 2008, Sonus Pharmaceuticals Inc. was acquired by OncoGenex Technologies Inc., in a reverse merger transaction. Sonus Pharmaceuticals, Inc. engages in the development of oncology drugs for the treatment of cancer primarily in the United States. Its principal product candidate includes SN2310 Injectable Emulsion, a Phase 1 clinical testing product, which is a novel camptothecin derivative. Camptothecins are a class of anti-cancer drugs. Sonus Pharmaceuticals also identified two areas of opportunity where it believe there is the possibility for improvements in patient treatments and can mitigate development risk: Prodrugs of existing small molecules, where the novel prodrug is ...

1522 217th Place SE

Suite 100

Bothell, WA 98021

United States

Founded in 1991

43 Employees





Key Executives for Sonus Pharmaceuticals Inc.

Sonus Pharmaceuticals Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Hyperion Therapeutics, Inc. United States
NeuMoDx Molecular, Inc. United States
Biocodex, Inc. United States
Calimmune, Inc. United States
Nexgenia Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sonus Pharmaceuticals Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at